Glycemic Control in Diabetic Hospitalized Patients

Sponsor

AlFayhaa General Hospital (Other)

Overall Status

Recruiting

CT.gov ID

NCT04800861

Collaborator

(none)

500

Enrollment

Location

5.9

Anticipated Duration (Months)

84.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

With the advanced management of diabetes and new innovative anti-hyperglycemic therapy hyperglycemia remains a culprit factor affecting the outcome of patients admitted to the hospital in general wards. Efforts from health care providers to assess and control blood sugar by a simplified method such as certified point of care hand-sized glucometers is the fruitful protocol if the results near the target that is endorsed by well-known diabetes societies. In non-critically patients the premeal blood sugar ≤140 mg /dl and ≤ 180 mg /dl after a meal. The unstable economy and political crises with the pandemic of Covid-19 making us use a glucometer to monitor and control the fluctuation of blood sugar in order to decrease the burden on the patients and health care providers in the form of a stay in the hospital and minimize wasting laboratory resources.

Condition or Disease	Intervention/Treatment	Phase
Diabetes Diabetes Mellitus

Study Design

Study Type:

Observational

Anticipated Enrollment :

500 participants

Observational Model:

Cohort

Time Perspective:

Cross-Sectional

Official Title:

Glycemic Control in Diabetic Hospitalized Patients: a Cross Sectional Study

Actual Study Start Date :

Jan 1, 2021

Anticipated Primary Completion Date :

Jul 1, 2021

Anticipated Study Completion Date :

Jul 1, 2021

Outcome Measures

Primary Outcome Measures

glycemic control [From hospital admission to hospital discharge for a median of 7 days and up to 1 month]
percentage of patients with glucose measurement (Random Blood Sugar, RBS, Fasting Blood Sugar, FBS) between 140-180 measured with bedside glucometers preferably before meals and at 6 am for fasting blood sugars or as directed by the physician

Secondary Outcome Measures

average blood glucose value per ward [From hospital admission to hospital discharge for a median of 7 days and up to 1 month]
average blood glucose value per ward (medical vs. surgical vs ICU/CCU
average per patient [From hospital admission to hospital discharge for a median of 7 days and up to 1 month]
average blood glucose levels per patient

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

admitted to the hospital

Exclusion Criteria:

none

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	AlFayhaa Teaching hospital	Basra		Iraq	99999

Sponsors and Collaborators

AlFayhaa General Hospital

Investigators

Study Chair: AbdulSattar J Yousif, MD, Al-Fayhaa teaching hospital
Study Chair: Ali Hussein A Alhamza, MD, Al-Fayhaa teaching hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

AlFayhaa General Hospital

ClinicalTrials.gov Identifier:

NCT04800861

Other Study ID Numbers:

1121

First Posted:

Mar 16, 2021

Last Update Posted:

Mar 16, 2021

Last Verified:

Mar 1, 2021

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by AlFayhaa General Hospital

Additional relevant MeSH terms:

Diabetes Mellitus

Study Results

No Results Posted as of Mar 16, 2021